Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells

Ahmed, 2007, M2-PK as a novel marker in ovarian cancer: a prospective cohort study, Eur J Gynaec Oncol, 28, 83 Akhtar, 2009, Differential behavior of missense mutations in the intersubunit contact domain of the human pyruvate kinase M2 isozyme, J Biol Chem, 284, 11971, 10.1074/jbc.M808761200 Allali-Hassani, 2009, A survey of proteins encoded by non-synonymous SNPs reveals a significant fraction with altered stability and activity, Biochem J, 424, 15, 10.1042/BJ20090723 Asai, 2003, Insulin stimulates expression of the pyruvate kinase M gene in 3T3-L1 adipocytes, Biosci Biotechnol Biochem, 67, 1272, 10.1271/bbb.67.1272 Ashizawa, 1991, In vivo regulation of monomer-tetramer conversion of pyruvate kinase subtype M2 by glucose is mediated via fructose 1,6-bisphosphate, J Biol Chem, 266, 16842, 10.1016/S0021-9258(18)55378-3 Bellance, 2009, Bioenergetics of lung tumors: alteration of mitochondrial biogenesis and respiratory capacity, Int J Biochem Cell Biol, 41, 2566, 10.1016/j.biocel.2009.08.012 Bellance, 2009, Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis, Front Biosci, 14, 4015 Boros, 1998, Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism?, Med Hypotheses, 50, 55, 10.1016/S0306-9877(98)90178-5 Brinck, 1994, L- and M2-pyruvate kinase expression in renal cell carcinomas and their metastases, Virchows Arch, 424, 177, 10.1007/BF00193498 Burd, 2001, Absence of Crabtree effect in human melanoma cells adapted to growth at low pH: reversal of respiratory inhibitors, Cancer Res, 61, 5630 Carbonell, 1973, Pyruvate kinase. Classes of regulatory isoenzymes in mammalian tissues, Eur J Biochem, 37, 148, 10.1111/j.1432-1033.1973.tb02969.x Christofk, 2008, The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth, Nature, 452, 230, 10.1038/nature06734 Christofk, 2008, Pyruvate kinase M2 is a phosphotyrosine-binding protein, Nature, 452, 181, 10.1038/nature06667 Cooper, 1983, Three glycolytic enzymes are phosphorylated at tyrosine in cells transformed by Rous sarcoma virus, Nature, 302, 218, 10.1038/302218a0 Cuezva, 2002, The bioenergetic signature of cancer: a marker of tumor progression, Cancer Res, 62, 6674 David, 2010, HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer, Nature, 463, 364, 10.1038/nature08697 DeBerardinis, 2007, Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis, Proc Natl Acad Sci U S A, 104, 19345, 10.1073/pnas.0709747104 Ding, 2004, Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials, Proteomics, 4, 982, 10.1002/pmic.200300653 Discher, 1998, Hypoxia regulates β-enolase and pyruvate kinase-M promoters by modulating Sp1/Sp3 binding to a conserved GC element, J Biol Chem, 273, 26087, 10.1074/jbc.273.40.26087 Dombrauckas, 2005, Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis, Biochemistry, 44, 9417, 10.1021/bi0474923 Domingo, 1992, Immunohistological demonstration of pyruvate kinase isoenzyme type L in rat with monoclonal antibodies, J Histochem Cytochem, 40, 665, 10.1177/40.5.1374093 Duan, 2007, Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8, J Natl Cancer Inst, 99, 1551, 10.1093/jnci/djm132 Eigenbrodt, 1983, Influence of transformation by Rous sarcoma virus on the amount, phosphorylation and enzyme kinetic properties of enolase, EMBO J, 2, 1565, 10.1002/j.1460-2075.1983.tb01625.x Eigenbrodt, 1994, Carbohydrate metabolism and neoplasia: new perspectives for diagnosis and therapy, 311 Eigenbrodt, 1980, Glycolysis—one of the keys to cancer?, Trends Pharmacol Sci, 1, 240, 10.1016/0165-6147(80)90009-7 Eigenbrodt, 1998, Double role of pyruvate kinase type M2 in the regulation of phosphometabolite pools, 15 Eigenbrodt, 1992, Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells, vol. 3, 91 Elia, 2008, Tumor type M2-pyruvate kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures, Eur J Cardiothorac Surg, 33, 723, 10.1016/j.ejcts.2008.01.014 Engel, 2004, Phosphoglycerate mutase derived polypeptide inhibits glycolytic flux and induces cell growth arrest in tumor cell lines, J Biol Chem, 279, 35803, 10.1074/jbc.M402768200 Fantin, 2006, Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance, Cancer Cell, 9, 425, 10.1016/j.ccr.2006.04.023 Funke, 2005, Membrane associated guanylate kinases regulate adhesion and plasticity at cell junctions, Annu Rev Biochem, 74, 219, 10.1146/annurev.biochem.74.082803.133339 Garcia-Gonzalo, 2003, Interaction between HERC1 and M2-type pyruvate kinase, FEBS Lett, 539, 78, 10.1016/S0014-5793(03)00205-9 Gatenby, 2004, Why do cancers have high aerobic glycolysis?, Nat Rev Cancer, 4, 891, 10.1038/nrc1478 Gottfried, 2006, Tumor-derived lactic acid modulates dendritic cell activation and antigen expression, Blood, 107, 2013, 10.1182/blood-2005-05-1795 Grimm, 1994, Immunoregulation by parental lipids: impact of the n-3 to n-6 fatty acid ratio, J Parenter Enteral Nutr, 18, 417, 10.1177/0148607194018005417 Hacker, 1998, Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet, Carcinogenesis, 19, 99, 10.1093/carcin/19.1.99 Hentze, 1994, Enzymes as RNA-binding proteins: a role for (di)nucleotide-binding domains?, Trends Biochem Sci, 19, 101, 10.1016/0968-0004(94)90198-8 Hervouet, 2006, Mitochondrial disorders in renal tumors, Mitochondrion, 6, 105, 10.1016/j.mito.2006.03.003 Hitosugi, 2009, Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth, Sci Signal, 2, ra73, 10.1126/scisignal.2000431 Huang, 2007, In vivo monitoring response to chemotherapy of human diffuse large B-cell lymphoma xenografts in SCID mice by 1H and 31P MRS, Acad Radiol, 14, 1531, 10.1016/j.acra.2007.07.012 Hoshino, 2007, Regulation of cell proliferation by interleukin-3-induced nuclear translocation of pyruvate kinase, J Biol Chem, 282, 17706, 10.1074/jbc.M700094200 Ignacak, 2003, The dual activity of pyruvate kinase type M2 from chromatin extracts of neoplastic cells, Comp Biochem Physiol Part B, 134, 425, 10.1016/S1096-4959(02)00283-X Irminger-Finger, 2007, Science of cancer and aging, J Clin Oncol, 25, 1844, 10.1200/JCO.2007.10.8928 Kato, 1989, Cytosolic thyroid hormone-binding protein is a monomer of pyruvate kinase, Proc Natl Acad Sci U S A, 86, 7861, 10.1073/pnas.86.20.7861 Kaura, 2004, Evaluation of the pyruvate kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma, J Obstet Gynaecol Res, 30, 193, 10.1111/j.1447-0756.2004.00187.x Kim, 2001, Potential mechanisms for the inhibition of tumor cell growth by manganese superoxide dismutase, Antioxid Redox Signal, 3, 361, 10.1089/15230860152409013 Kim, 2004, Evaluation of Myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation, Mol Cell Biol, 24, 5923, 10.1128/MCB.24.13.5923-5936.2004 Kress, 1998, Expression of hypoxia-inducible genes in tumor cells, J Cancer Res Clin Oncol, 124, 315, 10.1007/s004320050175 Kumar, 2007, Tumour M2-pyruvate kinase: a gastrointestinal cancer marker, Eur J Gastroenterol Hepatol, 19, 265, 10.1097/MEG.0b013e3280102f78 Lee, 2008, Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription, Int J Biochem Cell Biol, 40, 1043, 10.1016/j.biocel.2007.11.009 Le Mellay, 2002, Regulation of glycolysis by A-Raf protein serine/threonine kinase, Adv Enzyme Regul, 42, 317, 10.1016/S0065-2571(01)00036-X Lobo, 2000, Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells, Biochem J, 348, 257, 10.1042/0264-6021:3480257 Löffler, 2005, Pyrimidine pathways in health and disease, Trends Mol Med, 11, 430, 10.1016/j.molmed.2005.07.003 Lüftner, 2000, Tumor M2-pyruvate kinase expression in advanced breast cancer, Anticancer Res, 20, 5077 Makino, 1991, Phase variation of the opacity outer membrane protein controls invasion by Neisseria gonorrhoeae into human epithelial cells, EMBO J, 10, 1307, 10.1002/j.1460-2075.1991.tb07649.x Marchut, 1986, The inhibitory effect of various fatty acids on aerobic glycolysis in Ehrlich ascites tumor cells, Acta Biochim Pol, 33, 7 Marshall, 1991, Discovery of a metabolic pathway mediating glucose-induced desensitiziation of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance, J Biol Chem, 266, 4706, 10.1016/S0021-9258(19)67706-9 Martinez-Balibrea, 2009, A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines, Mol Cancer Ther, 8, 771, 10.1158/1535-7163.MCT-08-0882 Mayr, 2004, Loss of PKC-delta alters cardiac metabolism, Am J Physiol Heart Circ Physiol, 287, H937, 10.1152/ajpheart.00877.2003 Mazurek, 2005, Pyruvate kinase type M2 and its role in tumor growth and spreading, Semin Cancer Biol, 15, 300, 10.1016/j.semcancer.2005.04.009 Mazurek, 2007, Regulation of pyruvate kinase type M2 by A-Raf: a possible stop or go mechanism, Anticancer Res, 27, 3963 Mazurek, 2002, Pyruvate kinase type M2: a crossroad in the tumor metabolome, Br J Nutr, 87, S23, 10.1079/BJN2001454 Mazurek, 2000, Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells, Anticancer Res, 20, 5151 Mazurek, 1998, Metabolic characteristics of different malignant cancer cell lines, Anticancer Res, 18, 3275 Mazurek, 1996, Studies on associations of glycolytic and glutaminolytic enzymes in MCF-7 cells. Role of p36, J Cell Physiol, 167, 238, 10.1002/(SICI)1097-4652(199605)167:2<238::AID-JCP7>3.0.CO;2-Q Mazurek, 1997, Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates, J Biol Chem, 272, 4941, 10.1074/jbc.272.8.4941 Mazurek, 2001, Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyuvate kinase type M2 and the glycolytic enzyme complex, Biochem J, 356, 247, 10.1042/0264-6021:3560247 Mazurek, 2001, Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7, Oncogene, 20, 6891, 10.1038/sj.onc.1204792 Mazurek, 2008, Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours, 99, 10.1007/2789_2008_091 Melo, 1998, Occurence of the Crabtree effect in HeLa cells, Cell Biochem Func, 16, 99, 10.1002/(SICI)1099-0844(199806)16:2<99::AID-CBF773>3.0.CO;2-2 Miccheli, 2006, Metabolic profiling by 13C-NMR spectroscopy: [1,2-13C2] glucose reveals a heterogeneous metabolism in leukemia T cells, Biochimie, 88, 437, 10.1016/j.biochi.2005.10.004 Nagy, 1995, Glyceraldehyde 3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD+-binding region (Rossmann Fold), J Biol Chem, 270, 2755, 10.1074/jbc.270.6.2755 Netzker, 1992, Cell cycle-associated expression of M2-type isozyme of pyruvate kinase in proliferating rat thymocytes, J Biol Chem, 267, 6421, 10.1016/S0021-9258(18)42712-3 Netzker, 1997, Role of the stimulatory proteins Sp1 and Sp3 in the regulation of transcription of the rat pyruvate kinase M gene, Eur J Biochem, 245, 174, 10.1111/j.1432-1033.1997.00174.x Noguchi, 1986, The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing, J Biol Chem, 261, 13807, 10.1016/S0021-9258(18)67091-7 Noguchi, 1987, The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promotors, J Biol Chem, 262, 14366, 10.1016/S0021-9258(18)47947-1 Ohta, 2003, A multifunctional organelle mitochondrion is involved in cell death, proliferation and disease, Curr Med Chem, 10, 2485, 10.2174/0929867033456440 Oude Weernink, 1990, Phosphorylation of pyruvate kinase type K in human gliomas by a cyclic adenosine 5′-monophosphate-independent protein kinase, Cancer Res, 50, 4604 Parlo, 1984, Enhanced rate of citrate export from cholesterol-rich hepatoma mitochondria, J Biol Chem, 259, 9997, 10.1016/S0021-9258(18)90917-8 Piva, 1998, Oxidation of glutamine in HeLa cells: role and control of truncated TCA cycles in tumour mitochondria, J Cell Biochem, 68, 213, 10.1002/(SICI)1097-4644(19980201)68:2<213::AID-JCB8>3.0.CO;2-Y Presek, 1980, Similarities between a phosphoprotein (pp60src)-associated protein kinase of Rous sarcoma virus and a cyclic adenosine 3′:5′-monophosphate independent protein kinase that phosphorylates pyruvate kinase type M2, Cancer Res, 40, 1733 Presek, 1988, Pyruvate kinase type M2 is phosphorylated in tyrosine residues in cells transformed by Rous sarcoma virus, FEBS Lett, 242, 194, 10.1016/0014-5793(88)81014-7 Reinacher, 1981, Immunohistological demonstration of the same type of pyruvate kinase isoenzyme (M2-PK) in tumors of chicken and rat, Virchows Arch B Cell Pathol Incl Mol Pathol, 37, 79, 10.1007/BF02892557 Reinacher, 1979, Immunhistochemical localization of pyruvate kinase isoenzymes in chicken tissues, Histochemistry, 64, 145, 10.1007/BF00490095 Reitzer, 1979, Evidence that glutamine, not sugar, is the major energy source for cultured HeLa-cells, J Biol Chem, 254, 2669, 10.1016/S0021-9258(17)30124-2 Renner, 1972, Permeation of glucose by simple and facilitated diffusion by Novikoff rat hepatoma cells in suspension culture and its relationship to glucose metabolism, J Biol Chem, 247, 5765, 10.1016/S0021-9258(19)44825-4 Rodríguez-Enríquez, 2001, Multisite control of the Crabtree effect in ascites hepatoma cells, Eur J Biochem, 268, 2512, 10.1046/j.1432-1327.2001.02140.x Rodriguez-Horche, 1987, Comparative kinetic behaviour and regulation by fructose 1,6-P2 and ATP of pyruvate kinase from erythrocytes, reticulocytes and bone marrow cells, Comp Biochem Physiol, 87, 553, 10.1016/0305-0491(87)90051-4 Rosa, 1996, p619, a giant protein related to the chromosome condensation regulator RCC1, stimulates guanine nucleotide exchange on ARF1 and Rab proteins, EMBO J, 15, 4262, 10.1002/j.1460-2075.1996.tb00801.x Rossignol, 2004, Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells, Cancer Res, 64, 985, 10.1158/0008-5472.CAN-03-1101 Ryll, 1992, Intracellular ribonucleotide pools as a tool for monitoring the physiological state of in vitro cultivated mammalian cells during production processes, Biotechnol Bioeng, 40, 934, 10.1002/bit.260400810 Saheki, 1978, Hybrid isozymes of rat pyruvate kinase. Their subunit structure and developmental changes in the liver, Biochim Biophys Acta, 526, 116, 10.1016/0005-2744(78)90296-6 Saheki, 1979, Changes in pyruvate kinase isoenzymes of rat small intestine during development and the synergistic effect on them of thyroid and glucocorticoid hormones, Enzyme, 24, 8, 10.1159/000458623 Schäfer, 1997, Glucose regulates the promotor activity of aldolase A and pyruvate kinase M2 via dephosphorylation of Sp1, FEBS Lett, 417, 325, 10.1016/S0014-5793(97)01314-8 Schäfer, 1996, Differences in DNA-binding efficiency of SP1 to aldolase and pyruvate kinase promotor correlate with altered redox states in resting and proliferating rat thymocytes, FEBS Lett, 391, 35, 10.1016/0014-5793(96)00701-6 Schneider, 2002, Tumor M2-pyruvate kinase in lung cancer patients: Immunohistochemical detection and disease monitoring, Anticancer Res, 22, 311 Shimada, 2008, Modulation of M2-type pyruvate kinase activity by the cytoplasmic PML tumor suppressor protein, Genes Cells, 13, 245, 10.1111/j.1365-2443.2008.01165.x Shin, 2009, Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance, Electrophoresis, 30, 2182, 10.1002/elps.200800806 Shoffner, 2005, Oxidative phosphorylation disease: Diagnosis and Pathogenesis, 247 Siwko, 2007, Use of a novel method to find substrates of protein kinase C delta identifies M2 pyruvate kinase, Int J Biochem Cell Biol, 39, 978, 10.1016/j.biocel.2007.01.018 Spittler, 1997, Low glutamine concentrations inducephenotypical and functional differentiation of U937 myelomonocytic cells, J Nutr, 127, 2151, 10.1093/jn/127.11.2151 Spoden, 2008, Isotype-specific inhibitors of the glycolytic keyregulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation, Int J Cancer, 123, 312, 10.1002/ijc.23512 Spoden, 2009, The SUMO-E3 Ligase PIAS3 targets pyruvate kinase M2, J Cell Biochem, 107, 293, 10.1002/jcb.22125 Spoden, 2009, Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply, Exp Cell Res, 315, 2765, 10.1016/j.yexcr.2009.06.024 Staal, 1991, Pyruvate kinase in selected human tumors, 313 Steinberg, 1999, Expression of pyruvate kinase M2 in preneoplastic hepatic foci of N-nitrosomorpholine-treated rats, Virchows Arch, 434, 213, 10.1007/s004280050330 Stetak, 2007, Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death, Cancer Res, 67, 1602, 10.1158/0008-5472.CAN-06-2870 Takahashi, 2007, The roles pf PET and PET/CT in the diagnosis and management of prostate cancer, Oncology, 72, 226, 10.1159/000112946 Takenaka, 1989, Rat pyruvate kinase M gene. Its complete structure and characterization of the 5′flanking region, J Biol Chem, 264, 2363, 10.1016/S0021-9258(18)94185-2 Takenaka, 1996, Alternative splicing of the pyruvate kinase M gene in a minigene system, Eur J Biochem, 235, 366, 10.1111/j.1432-1033.1996.00366.x Tonus, 2006, Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK, World J Gastroenterol, 12, 7007, 10.3748/wjg.v12.i43.7007 Traweger, 2007, Nuclear zonula occludens-2 alters gene expression and junctional stability in epithelial and endothelial cells, Differentiation, 76, 99, 10.1111/j.1432-0436.2007.00227.x Traxinger, 1992, Insulin regulation of pyruvate kinase activity in isolated adipocytes. Crucial role of glucose and the hexosamine biosynthesis pathway in the expression of insulin action, J Biol Chem, 267, 9718, 10.1016/S0021-9258(19)50150-8 Ugurel, 2005, Tumor type M2 pyruvate kinase (TuM2-PK) as novel plasma tumor marker, Int J Cancer, 117, 825, 10.1002/ijc.21073 Vander Heiden, 2010, Identification of small molecule inhibitors of pyruvate kinase M2, Biochem Pharmacol, 79, 1118, 10.1016/j.bcp.2009.12.003 Walenta, 2004, Lactate: mirror and motor of tumor malignancy, Semin Radiat Oncol, 14, 267, 10.1016/j.semradonc.2004.04.004 Wang, 1998, Role of PML in cell growth and the retinoic acid pathway, Science, 279, 1547, 10.1126/science.279.5356.1547 Warburg, 1924, Über den Stoffwechsel der Tumoren, Biochem Z, 152, 319 Weber, 2002, Cultivation in glucose-deprived medium stimulates mitochondrial biogenesis and oxidative metabolism in HepG2 hepatoma cells, Biol Chem, 383, 283, 10.1515/BC.2002.030 Wechsel, 1999, Marker for renal cell carcinoma (RCC): The dimeric form of pyruvate kinase type M2 (Tu M2-PK), Anticancer Res, 19, 2583 Williams, 1998, Using the yeast two-hybrid system to identify human epithelial cell proteins that bind gonococcal Opa proteins: intracellular gonococci bind pyruvate kinase via their Opa proteins and require host pyruvate for growth, Mol Microbiol, 27, 171, 10.1046/j.1365-2958.1998.00670.x Witney, 2009, A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized 31-C-labaled pyruvate utilization as methods for detecting tumor response to treatment, Neoplasia, 11, 574, 10.1593/neo.09254 Wong, 2008, Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling, Int J Cancer, 123, 251, 10.1002/ijc.23583 Wu, 2008, Isoform specific interaction of pyruvate kinase with hepatitis C virus NS5B, FEBS Lett, 582, 2155, 10.1016/j.febslet.2008.05.033 Yamada, 1999, Nutrient and hormonal regulation of pyruvate kinase gene expression, Biochem J, 337, 1, 10.1042/0264-6021:3370001 Yamada, 1999, Regulation of pyruvate kinase M gene expression, Biochem Biophys Res Commun, 256, 257, 10.1006/bbrc.1999.0228 Yoo, 2004, Decreased pyruvate kinase M2 activity linked to cisplatin resistance in human gastric carcinoma cell lines, Int J Cancer, 108, 532, 10.1002/ijc.11604 Zebisch, 2006, Back to the roots: the remarkable RAF oncogene story, Cell Mol Life Sci, 63, 1314, 10.1007/s00018-006-6005-y Zur Hausen, 2002, Papillomaviruses and cancer: from basic studies to clinical applications, Nat Rev Cancer, 2, 342, 10.1038/nrc798 Zwerschke, 1999, Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein, Proc Natl Acad Sci U S A, 96, 1291, 10.1073/pnas.96.4.1291 Zwerschke, 2003, Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence, Biochem J, 376, 403, 10.1042/bj20030816